This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08533/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB08533/identifier/pdb/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/resource/drugbank/drug/DB08533/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08533/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08533/identifier/drugbank/

Statements

Subject Item
n2:DB08533
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB08533 n13:DB08533
dcterms:title
3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine
adms:identifier
n4:SCE n5:9991833 n11:8167415 n12:DB08533 n14:99445004
n6:IUPAC-Name
n7:271B6152-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B6158-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B6157-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B6154-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B6155-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B6156-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B6150-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B614E-363D-11E5-9242-09173F13E4C5 n7:271B6151-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B614F-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B615E-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B615F-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B6159-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B615A-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B615C-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B615B-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B615D-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B6164-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B6166-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B6167-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B6163-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B6162-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B6165-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B6153-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B6160-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B6161-363D-11E5-9242-09173F13E4C5